Official Website: Owlet Baby Care
source confidence: Medium status: Useful updated 2026-06-19
Summary
Owlet's official website describes connected nursery products for infant monitoring, including FDA-cleared sock monitors, video monitors, bundled systems, and a prescription pulse-oximeter product for medical use at home.
Useful Claims
- Owlet markets Dream Sock as an FDA-cleared best seller that monitors pulse rate, oxygen, and sleep in real time while the baby sleeps.
- Dream Sight is presented as a smart HD video baby monitor.
- Dream Duo is described as an integrated baby monitoring system combining sock and camera capabilities.
- An earlier version of this page described BabySat as FDA-cleared and Rx-only, with provider-guided customizable pulse and oxygen alarm limits; none of those details appears in this homepage capture.
- The site says Owlet tools have monitored billions of hours of baby sleep and promotes real-time alerts for vitals, cry, motion, and sound.
- The capture contains a Dream Sock/Dream Sight promotion, but does not support the earlier HSA/FSA eligibility claim.
Verbatim
"Support baby's wellbeing and development with tools that have monitored billions of hours of baby sleep." — Home page
"FDA-Cleared Best Seller Dream Sock®" — Home page, Dream Sock card
"Monitor your baby’s pulse rate, oxygen, and sleep in real time." — Home page, monitoring features
"Real-time alerts for vitals, cry, motion, and sound, so you can act fast and worry less." — Home page, alerts
Reliability Notes
The capture does not describe BabySat, Rx-only status, healthcare-provider guidance, customized alarm limits, or HSA/FSA eligibility. Those claims need a product-page capture rather than this homepage artifact.
This is an official company source. FDA clearance labels and wellness claims on a company site are leads, not independent verification of safety or clinical benefit. Regulatory status, intended use, and marketing boundaries for each SKU should be confirmed against FDA databases, product labeling, and third-party reporting — especially given Owlet's history of FDA scrutiny over prior Smart Sock marketing.